The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/hyperactivity disorder and severe mood dysregulation (Q37186841)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 2008

Language	Label	Description	Also known as
English	The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/hyperactivity disorder and severe mood dysregulation	scientific article published on December 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/hyperactivity disorder and severe mood dysregulation (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

attention deficit hyperactivity disorder

0 references

1 reference

based on heuristic

inferred from title

Greta M. Massetti

object named as

Greta A Massetti

9

0 references

object named as

Anil Chacko

13

0 references

Daniel A Waschbusch

object named as

Daniel A Waschbusch

12

0 references

Elizabeth M Gnagy

3

object named as

Elizabeth Gnagy

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

author name string

James Waxmonsky

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

William E Pelham

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Michael R Cummings

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Briannon O'Connor

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Antara Majumdar

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Jessica Verley

7

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Martin T Hoffman

8

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Lisa Burrows-MacLean

10

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Gregory A Fabiano

11

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Frances W Arnold

14

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Kathryn S Walker

15

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Allison C Garefino

16

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Jessica A Robb

17

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

publication date

1 December 2008

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Journal of Child and Adolescent Psychopharmacology

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

18

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

573-588

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Autism spectrum disorder scale scores in pediatric mood and anxiety disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Practice parameter for the assessment and treatment of children and adolescents with depressive disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

National trends in the outpatient diagnosis and treatment of bipolar disorder in youth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996-2004

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Pharmacological interventions for bipolar youth: developmental considerations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Diagnostic and measurement issues in the assessment of pediatric bipolar disorder: implications for understanding mood disorder across the life cycle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Clinical course of children and adolescents with bipolar spectrum disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Pediatric bipolar disorder: a review of the past 10 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Treatment guidelines for children and adolescents with bipolar disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Comparing the diagnostic accuracy of six potential screening instruments for bipolar disorder in youths aged 5 to 17 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Clinical implications of pervasive manic symptoms in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Defining clinical phenotypes of juvenile mania

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Discriminative validity of a parent version of the Young Mania Rating Scale

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Severity of bipolarity in hospitalized manic adolescents with history of stimulant or antidepressant treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Can stimulant rebound mimic pediatric bipolar disorder?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Long-term effects of stimulant medications on the brain: possible relevance to the treatment of attention deficit hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

The Mania Rating Scale: can it be used in children? A preliminary report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

A rating scale for mania: reliability, validity and sensitivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

6 September 2017

Psychoeducational treatment for school-aged children with bipolar disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

14 September 2017

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

28 September 2017

Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

26 June 2018

Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

26 June 2018

Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

Olanzapine versus placebo in the treatment of adolescents with bipolar mania

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

Specificity of facial expression labeling deficits in childhood psychopathology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

Parental diagnoses in youth with narrow phenotype bipolar disorder or severe mood dysregulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

Cognitive flexibility in phenotypes of pediatric bipolar disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

Different psychophysiological and behavioral responses elicited by frustration in pediatric bipolar disorder and severe mood dysregulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

Prevalence, clinical correlates, and longitudinal course of severe mood dysregulation in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

A pilot study of antidepressant-induced mania in pediatric bipolar disorder: Characteristics, risk factors, and the serotonin transporter gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

A practical measure of impairment: psychometric properties of the impairment rating scale in samples of children with attention deficit hyperactivity disorder and two school-based samples.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

Early symptoms of mania and the role of parental risk.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

Children with a prepubertal and early adolescent bipolar disorder phenotype from pediatric versus psychiatric facilities.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

Child- and family-focused cognitive-behavioral therapy for pediatric bipolar disorder: development and preliminary results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

Is there progression from irritability/dyscontrol to major depressive and manic symptoms? A retrospective community survey of parents of bipolar children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

Drug-induced disinhibition in psychiatrically hospitalized children.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

Anxiety and depression symptoms and response to methylphenidate in children with attention-deficit hyperactivity disorder and tic disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

Manic symptoms in psychiatrically hospitalized children--what do they mean?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

Young referred boys with DICA-P manic symptoms vs. two comparison groups

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

The naturalistic course of pharmacologic treatment of children with maniclike symptoms: a systematic chart review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

3 September 2018

A prospective follow-up study of pediatric bipolar disorder in boys with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680095

4 December 2018

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

https://pubmed.ncbi.nlm.nih.gov/19108662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19108662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulant treatment in young boys with symptoms suggesting childhood mania: a report from a longitudinal study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19108662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factor structure of the Young Mania Rating Scale for use with youths ages 5 to 17 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/19108662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Earlier onset of bipolar disorder in children by antidepressants or stimulants? An hypothesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19108662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary studies of the reliability and validity of the children's depression rating scale

1 reference

https://pubmed.ncbi.nlm.nih.gov/19108662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/19108662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Separate and combined effects of methylphenidate and behavior modification on boys with attention deficit-hyperactivity disorder in the classroom

1 reference

https://pubmed.ncbi.nlm.nih.gov/19108662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania

1 reference

https://pubmed.ncbi.nlm.nih.gov/19108662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response and remission in adolescent mania: signal detection analyses of the young mania rating scale

1 reference

https://pubmed.ncbi.nlm.nih.gov/19108662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1089/CAP.2008.065

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37186841&oldid=2138990357"